Specifically, the GUIGOZ Bio 2 and 3 infant milk range will be traced on the blockchain platform as a means to provide consumers with more information on the milks origins and transparency on product checks, Carrefour said in an announcement on Thursday. Customers will be able to scan a QR code on the milk’s packaging to access a range of information.
Nothing is more important to new parents than the safety of their infants, and food giants Nestle and Carrefour aim to use blockchain to help appease that instinct.
Following on from a previous food tracking effort by the two companies, based on IBM’s Food Trust platform, Nestle and Carrefour will track baby milk products and provide consumers with data on their origins and movements “from dairy to shelf.”
“Blockchain technology enhances transparency and advances the food transition for extremely high-quality products, which parents expect for infant nutrition. For Nestle and Laboratoires Guigoz, this innovative blockchain technology creates a new benchmark for transparency and the high standards of care required to ensure the quality of their products,” the firm said.
While such schemes may have an element of marketing, there’s no doubt that breakdowns in food safety – such as China’s melamine-adulterated milk scandal and the more recently reported Polish distribution of diseased meat – have raised concerns over what we are being fed.
Other major firms – like Cargill and Walmart – have moved to utilize blockchain tech ease those concerns, in theory, providing consumers with immutable proof that their food comes from where it’s supposed to and hasn’t been adulterated along the way.
Back in February, French President Emmanuel Macron called for increased use of data technologies such as blockchain in the EU, in part to address concerns over food traceability.
Nervos Aims to Spur Blockchain Development With New Incubator Headed by Industry Vet
Public blockchain network Nervos has launched a virtual incubator for early-stage startups building decentralized applications (dapps).
Dubbed CK Labs, the incubator will fund startups developing their dapps on Nervos’ platform and introduce the products to major crypto investors to help bring products to market. The firm thinks the incubator can help further develop its own two-layer blockchain platform, too.
CK Labs comes a few months after the open source network pledged to award $30 million in grants to development teams that help Nervos improve its layer one infrastructure.
“There are still many more infrastructure improvements to come, but the launch of CK Labs marks the next phase of Nervos as we start expanding the network’s utility with dapps and Layer 2 solutions,” Kevin Wang, co-founder of Nervos, told CoinDesk.
The firm will initially allocate $5 million to help the startups bring their products to market while providing them with access to major crypto venture capital firms including Polychain Capital, Multicoin Capital, Dragonfly Capital and 1confirmation.
According to Nervos, any startup with an existing minimum viable product could apply for, and potentially receive, up to $100,000 in equity-free capital plus join a four-month program designed to help the teams get a deeper understanding of the Nervos’ infrastructure and the resources needed to launch or scale products on the network.
Founded in 2018, the San Francisco-based Nervos has raised over $100 million. It secured a $28 million Series A funding led by Polychain and Sequoia China in July 2018 and a $72 million token sale in November. Its two-layer open network aims to maintain as high a level of security as the Bitcoin network, while increasing scalability through a side chain.
CK Labs will be headed by Ben Morris. Morris comes from Status, an Ethereum-based messaging platform where he headed its incubator program. He led investments into Matrix, Pixura and LeapDAO, three startups focused on improving the scalability of Ethereum-based networks.
Before that Morris worked as Head of Treasury Specialists at Thomson Reuters out of Dubai and was eCommerce business development manager at Bloomberg from Singapore.
“The CK Labs program was specifically designed to accelerate teams focused on ushering in the first wave of adoption,” Morris said. “Given the versatility of Nervos, we want to invite founders from all business verticals to apply.”
The firm said applications for the first batch of CK Labs are now being accepted. The program will run several times every year with two to four teams each to ensure they get personalized support.